Retinal Disorders in Patients with Type 2 Diabetes In a trial of adult patients with type 2 diabetes and BMI greater than or equal to 27 kg/m 2 for weight reduction, retinal disorders were reported by 6.9% of patients treated with WEGOVY (semaglutide 2.4 mg), 6.2% of patients treated with semaglutide 1 mg, and 4.2% of patients treated with placebo
E., Li, H., Giovannucci, E., Lee, I
Store Away From Heat and Direct Sunlight Even at room temperature, tirzepatide must be stored carefully
It comes in four strengths (500 mg, 750 mg, 850 mg, and 1,000 mg), and a typical adult starts at one of the three lower doses once or twice daily, with gradual dose increases as needed
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment
In some cases, adjustments to the dosage or alternative treatments may be recommended